Increased regulatory T cells in acute lymphoblastic leukemia patients by Idris, Siti Zuleha et al.
 
Increased regulatory T cells in acute lymphoblastic leukemia patients 
ABSTRACT 
Introduction: Regulation in adaptive immune response balances a fine line that 
prevents instigation of self-damage or fall into unresponsiveness permitting abnormal 
cell growth. Mechanisms that keep this balance in check include regulatory T cells 
(Tregs). Tregs consist of a small but heterogeneous population which may be 
identified by the phenotype, CD3+CD4+CD25+CD127-. Role of Tregs in 
pathogenesis of cancers is thus far supported by evidence of increased Tregs in 
various cancers and may contribute to poorer prognosis. Tregs may also be important 
in acute leukemias. Objective: A review of the literature on Tregs in acute leukemias 
was conducted and Tregs were determined in B-cell acute lymphoblastic leukemias 
(ALLs). Results: Studies on Tregs in B-cell ALL are few and controversial. We 
observed a significantly increased percentage of Tregs (mean ± SD, 9.72 ± 3.79% vs. 
7.05 ± 1.74%; P = 0.047) in the bone marrow/peripheral blood of ALL (n = 17) 
compared to peripheral blood of normal controls (n = 35). A positive trend between 
Tregs and age (R = 0.474, P = 0.055, n = 17) implicates this factor of poor prognosis 
in B-cell ALL. Discussion: Tregs in cancer are particularly significant in 
immunotherapy. The manipulation of the immune system to treat cancer has for a 
long time ignored regulatory mechanisms inducible or in place. In lymphoma studies 
tumor-specific mechanisms that are unlike conventional methods in the induction of 
Tregs have been hypothesized. In addition, tumor-infiltrating Tregs may present 
different profiles from peripheral blood pictures. Tregs will continue to be dissected 
to reveal their mysteries and their impact on clinical significance. 
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